Pura Vida Investments as of March 31, 2018
Portfolio Holdings for Pura Vida Investments
Pura Vida Investments holds 67 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ICU Medical, Incorporated (ICUI) | 6.1 | $7.1M | 28k | 252.40 | |
| Globus Med Inc cl a (GMED) | 5.8 | $6.7M | 135k | 49.82 | |
| Livanova Plc Ord (LIVN) | 5.5 | $6.4M | 72k | 88.50 | |
| Merck & Co (MRK) | 4.8 | $5.6M | 102k | 54.47 | |
| Alexion Pharmaceuticals | 4.3 | $5.0M | 45k | 111.46 | |
| Baxter International (BAX) | 4.2 | $4.9M | 75k | 65.04 | |
| Invacare Corporation | 4.1 | $4.8M | 277k | 17.40 | |
| Intersect Ent | 3.7 | $4.3M | 110k | 39.30 | |
| Abbott Laboratories (ABT) | 3.1 | $3.6M | 61k | 59.92 | |
| athenahealth | 3.1 | $3.6M | 25k | 143.03 | |
| BioMarin Pharmaceutical (BMRN) | 3.0 | $3.5M | 44k | 81.07 | |
| Edwards Lifesciences (EW) | 3.0 | $3.5M | 25k | 139.52 | |
| Medtronic (MDT) | 2.9 | $3.4M | 43k | 80.22 | |
| Sientra | 2.5 | $2.9M | 299k | 9.66 | |
| Dex (DXCM) | 2.4 | $2.8M | 37k | 74.16 | |
| Viewray (VRAYQ) | 2.3 | $2.7M | 422k | 6.43 | |
| Qiagen Nv | 2.1 | $2.4M | 75k | 32.31 | |
| Boston Scientific Corporation (BSX) | 2.0 | $2.4M | 88k | 27.32 | |
| Orthofix International Nv Com Stk | 2.0 | $2.4M | 40k | 58.78 | |
| United Therapeutics Corporation (UTHR) | 1.9 | $2.2M | 20k | 112.36 | |
| Rigel Pharmaceuticals | 1.8 | $2.1M | 591k | 3.54 | |
| Zogenix | 1.7 | $2.0M | 50k | 40.05 | |
| Arena Pharmaceuticals | 1.7 | $2.0M | 50k | 39.50 | |
| Natus Medical | 1.7 | $1.9M | 58k | 33.65 | |
| Halyard Health | 1.6 | $1.8M | 40k | 46.08 | |
| Allergan | 1.5 | $1.7M | 10k | 168.29 | |
| Amicus Therapeutics (FOLD) | 1.3 | $1.5M | 100k | 15.04 | |
| Cardiovascular Systems | 1.3 | $1.5M | 67k | 21.93 | |
| Nuvectra | 1.3 | $1.5M | 113k | 13.02 | |
| Rocket Pharmaceuticals (RCKT) | 1.1 | $1.3M | 72k | 18.75 | |
| Transenterix | 1.1 | $1.3M | 781k | 1.70 | |
| Incyte Corporation (INCY) | 1.1 | $1.3M | 16k | 83.33 | |
| Glaukos (GKOS) | 1.1 | $1.2M | 40k | 30.83 | |
| Conformis | 0.9 | $1.1M | 731k | 1.45 | |
| Kala Pharmaceuticals | 0.9 | $1.0M | 65k | 15.83 | |
| Aduro Biotech | 0.8 | $930k | 100k | 9.30 | |
| Evolus (EOLS) | 0.8 | $926k | 103k | 9.03 | |
| Exelixis (EXEL) | 0.8 | $886k | 40k | 22.15 | |
| Biohaven Pharmaceutical Holding | 0.7 | $834k | 32k | 25.76 | |
| Aimmune Therapeutics | 0.7 | $821k | 26k | 31.83 | |
| Acer Therapeutics | 0.7 | $805k | 42k | 19.27 | |
| Viking Therapeutics (VKTX) | 0.7 | $764k | 175k | 4.37 | |
| Clearside Biomedical (CLSD) | 0.6 | $726k | 68k | 10.73 | |
| Tg Therapeutics (TGTX) | 0.6 | $710k | 50k | 14.20 | |
| Steadymed | 0.6 | $699k | 215k | 3.25 | |
| Versartis | 0.6 | $671k | 407k | 1.65 | |
| Otonomy | 0.6 | $640k | 153k | 4.20 | |
| Fate Therapeutics (FATE) | 0.5 | $582k | 60k | 9.76 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $563k | 5.0k | 112.67 | |
| Jounce Therapeutics | 0.4 | $485k | 22k | 22.35 | |
| Accuray Incorporated (ARAY) | 0.4 | $460k | 92k | 5.00 | |
| Viveve Med | 0.2 | $269k | 74k | 3.66 | |
| Spectrum Pharmaceuticals | 0.2 | $213k | 1.0k | 212.50 | |
| Newlink Genetics Corporation | 0.2 | $210k | 613.00 | 342.50 | |
| Health Care SPDR (XLV) | 0.1 | $159k | 1.6k | 99.50 | |
| Foamix Pharmaceuticals | 0.1 | $124k | 24k | 5.13 | |
| CIGNA Corporation | 0.1 | $93k | 350.00 | 266.50 | |
| Array BioPharma | 0.1 | $94k | 500.00 | 187.50 | |
| Coherus Biosciences (CHRS) | 0.0 | $46k | 500.00 | 92.50 | |
| Bristol Myers Squibb (BMY) | 0.0 | $35k | 1.0k | 35.00 | |
| Histogenics Corp Cmn | 0.0 | $37k | 14k | 2.75 | |
| Vascular Biogenics | 0.0 | $30k | 1.0k | 30.00 | |
| Amgen (AMGN) | 0.0 | $22k | 100.00 | 219.50 | |
| AVEO Pharmaceuticals | 0.0 | $8.0k | 3.2k | 2.50 | |
| Edge Therapeutics | 0.0 | $14k | 10.00 | 1400.00 | |
| Celldex Therapeutics | 0.0 | $650.000000 | 20.00 | 32.50 | |
| Anthera Pharmaceuticals (ANTH) | 0.0 | $2.3k | 912.00 | 2.50 |
